Literature DB >> 29092728

Extensive gastric mucosal atrophy is a possible predictor of clinical effectiveness of acotiamide in patients with functional dyspepsia
.

Atsushi Miki, Takatsugu Yamamoto, Kyohei Maruyama, Naohiro Nakamura, Hitoshi Aoyagi, Akari Isono, Koichiro Abe, Hiroto Kita.   

Abstract

BACKGROUND: Acotiamide is known as an effective agent for functional dyspepsia. However, clinical factors related to its effectiveness have not been fully elucidated, so it is difficult to predict the drug's effectiveness prior to its administration in patients. AIMS: The present retrospective study was conducted to examine the relationship between clinical factors and the effectiveness of acotiamide for functional dyspepsia.
MATERIALS AND METHODS: The study subjects were 149 patients with functional dyspepsia who were prescribed acotiamide. Based on medical records and clinical factors, including endoscopic findings, the effectiveness of acotiamide was investigated.
RESULTS: Significant clinical factors associated with acotiamide's effectiveness were identified. These included postprandial syndrome, concomitant mental disorder, and extensive gastric mucosal atrophy. On multiple regression analysis, extensive gastric mucosal atrophy showed the strongest relationship with the clinical effectiveness of acotiamide; the other significant factor was concomitant mental disorder.
CONCLUSION: Although the pathophysiology of the relationship between mucosal atrophy and acotiamide remains uncertain, a decrease in hormonal secretion, such as that of ghrelin, may be a possible mechanism.
.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29092728     DOI: 10.5414/CP203016

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  2 in total

1.  Histopathological classification and follow-up analysis of chronic atrophic gastritis.

Authors:  Yang-Kun Wang; Lan Shen; Tian Yun; Bin-Feng Yang; Chao-Ya Zhu; Su-Nan Wang
Journal:  World J Clin Cases       Date:  2021-06-06       Impact factor: 1.337

2.  Efficacy of acotiamide on postprandial distress syndrome and epigastric pain syndrome depending on the estimated gastric acid secretion level.

Authors:  Toshiaki Suzuki; Reina Ohba; Ei Kataoka; Yui Kudo; Akira Zeniya; Daisuke Segawa; Keisuke Oikawa; Masaru Odashima; Taiji Saga; Tomoyuki Kuramitsu; Hideaki Sasahara; Kazuo Yoneyama; Takashi Tomita; Yosuke Shimodaira; Katsunori Iijima
Journal:  J Neurogastroenterol Motil       Date:  2022-01-30       Impact factor: 4.924

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.